Disclosure Similarity and Future Stock Return Comovement
Management Science · 2024-07 · 70 (7) · 4762-4780
DOI: 10.1287/mnsc.2023.4915 ↗Kurz gefasst
Fachartikel in der Zeitschrift Management Science, 2024-07. Verfasst von Travis A. Dyer und 2 weiteren Autor:innen. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Existing research often assumes that firms’ financial reporting choices influence their return comovement with other firms. We examine the validity of that assumption. First, we provide initial evidence suggesting that similarity in two firms’ disclosures not only predicts but influences future return comovement between those two firms. Second, we show that this predictive ability aggregates to the market level; disclosure similarity can be used to estimate more accurate forward-looking market betas. Taken together, these two results suggest that firms’ reporting decisions can influence their firms’ betas even in the absence of changes to capital structure or operations. This paper was accepted by Suraj Srinivasan, accounting. Funding: The authors are grateful for financial support from the Brigham Young University Marriott School of Business and the Fisher College of Business, Ohio State University. Supplemental Material: The data files are available at https://doi.org/10.1287/mnsc.2023.4915 .
Zitieren
APA
Dyer, T. A., Roulstone, D. T., & Buskirk, A. V. (2024). Disclosure Similarity and Future Stock Return Comovement. Management Science, 70(7), 4762-4780. https://doi.org/10.1287/mnsc.2023.4915
Vancouver
Dyer TA, Roulstone DT, Buskirk AV. Disclosure Similarity and Future Stock Return Comovement. Management Science. 2024;70(7):4762-4780. doi:10.1287/mnsc.2023.4915
BibTeX
@article{Dyer2024,
author = {Dyer, Travis A. and Roulstone, Darren T. and Buskirk, Andrew Van},
title = {Disclosure Similarity and Future Stock Return Comovement},
journal = {Management Science},
year = {2024},
volume = {70},
number = {7},
pages = {4762--4780},
doi = {10.1287/mnsc.2023.4915}
}
EUVIMED